-
EP3896068
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3896068
| EP3896068 - S1P3 ANTAGONISTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.11.2023 Database last updated on 03.09.2024 | |
| Former | Examination is in progress Status updated on 05.05.2023 | ||
| Former | Request for examination was made Status updated on 22.04.2022 | ||
| Former | The application has been published Status updated on 17.09.2021 | Most recent event Tooltip | 10.11.2023 | Application deemed to be withdrawn | published on 13.12.2023 [2023/50] | Applicant(s) | For all designated states Teva Pharmaceutical Industries Ltd. 124 Dvora HaNevi'a St. Tel Aviv 6944020 / IL | [2021/46] |
| Former [2021/42] | For all designated states Teva Pharmaceutical Industries Limited 5 Basel Street Petach Tikva 4951033 / IL | Inventor(s) | 01 /
CARAMELLI, Chiara Via Rossini 14 53018 Sovicille (SI) / IT | 02 /
FEDERICO, Cesare Via del Luschieto 95 06126 Perugia (PG) / IT | 03 /
GABELLIERI, Emanuele Avenue Parc de la Rouvraie 10 1018 Lausanne / CH | 04 /
MAGNANI, Matteo Via Sandro Pertini 9 52015 Pratovecchio (AR) / IT | 05 /
MICCO, Iolanda 10 Dover Rise Heritage View Tower B 10-18 138680 Singapore / SG | 06 /
TERSTAPPEN, Georg C. Panoramastrasse 11 67271 Battenberg (PFALZ) / DE | [2021/42] | Representative(s) | D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
| Former [2021/42] | D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 21155292.2 | 28.11.2014 | [2021/42] | Priority number, date | EP20130195372 | 02.12.2013 Original published format: EP 13195372 | [2021/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3896068 | Date: | 20.10.2021 | Language: | EN | [2021/42] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.08.2021 | Classification | IPC: | C07D403/12, C07D401/12, C07D213/75, A61K31/444, A61P29/00 | [2021/42] | CPC: |
C07D213/75 (EP,EA,KR,US);
A61K31/444 (EA,KR);
A61P29/00 (EP);
C07D241/16 (EP,EA,US);
C07D277/32 (EP,EA,US);
C07D401/12 (EP,EA,KR,US);
C07D401/14 (EP,EA,US);
C07D403/12 (EP,EA,KR,US);
C07D405/14 (EP,EA,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/21] |
| Former [2021/42] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | S1P3-ANTAGONISTEN | [2021/42] | English: | S1P3 ANTAGONISTS | [2021/42] | French: | ANTAGONISTES DU S1P3 | [2021/42] | Examination procedure | 20.04.2022 | Amendment by applicant (claims and/or description) | 20.04.2022 | Examination requested [2022/21] | 20.04.2022 | Date on which the examining division has become responsible | 08.05.2023 | Despatch of a communication from the examining division (Time limit: M02) | 19.07.2023 | Application deemed to be withdrawn, date of legal effect [2023/50] | 08.08.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/50] | Parent application(s) Tooltip | EP14811790.6 / EP3086845 | EP19210115.2 / EP3689864 | Fees paid | Renewal fee | 23.03.2021 | Renewal fee patent year 03 | 23.03.2021 | Renewal fee patent year 04 | 23.03.2021 | Renewal fee patent year 05 | 23.03.2021 | Renewal fee patent year 06 | 23.03.2021 | Renewal fee patent year 07 | 24.11.2021 | Renewal fee patent year 08 | 24.11.2022 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2008141013 (ALLERGAN INC [US], et al) [A] 1-12 * page 1, line 13 - line 15; claim 3; table 1 *; | [A]WO2011019681 (ALLERGAN INC [US], et al) [A] 1-12* paragraph [0002]; claim 1; table 2 *; | [A] - MIGUEL GUERRERO ET AL, "Discovery, design and synthesis of a selective S1P3 receptor allosteric agonist", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (20131201), vol. 23, no. 23, doi:10.1016/j.bmcl.2013.09.075, ISSN 0960-894X, pages 6346 - 6349, XP055107070 [A] 1-12 * figure 1 * DOI: http://dx.doi.org/10.1016/j.bmcl.2013.09.075 | by applicant | EP0081756 | WO9815278 | WO0026202 | WO0136415 | US2001039344 | WO0183465 | JP2002155065 | WO0246173 | WO03063797 | US6610846 | WO03095438 | WO2004052869 | WO2005075435 | WO2006058923 | WO2007026761 | WO2007041365 | WO2007087066 | US2007281942 | WO2008005914 | WO2008078674 | WO2008119734 | WO2008141119 | WO2008147797 | WO2009006315 | WO2009091014 | WO2009123896 | WO2009140624 | US2010063063 | WO2010054138 | - WANG et al., Bioorganic & Medicinal Chemistry Letters, (20100000), vol. 20, no. 2, pages 493 - 498 | - Ingyong Huaxue, (19900000), vol. 7, no. 6, pages 54 - 7 | - Journal of Medicinal Chemistry, (20120000), vol. 55, no. 16, pages 7021 - 7036 | - Medicinal Chemistry Letters, (20130000), vol. 4, no. 4, pages 414 - 418 | - Journal of Medicinal Chemistry, (20100000), vol. 53, no. 9, pages 3618 - 3625 | - TENGEIJI et al., Molecules, (20120000), vol. 17, pages 7356 - 7378 | - XIANG WANG et al., J. Org. Chem., (20080000), vol. 73, pages 1643 - 1645 | - HARTWIG, J.F. et al., JACS, (20030000), vol. 125, pages 11176 - 11177 | - MAKOTO et al., Organic Letters, (20060000), vol. 8, pages 3805 - 3808 | - ANELLI, V.BASSI, R.TETTAMANTI, G.VIANI, P.RIBONI, L., "Extracellular release of newly synthesized sphingosine-1-phosphate by cerebellar granule cells and astrocytes", J. Neurochem., (20050000), vol. 92, pages 1204 - 1215 | - BAJWA AHUANG LYE HDONDETI KSONG SROSIN DLLYNCH KRLOBO PILI LOKUSA MD, "Dendritic cell sphingosine 1-phosphate receptor-3 regulates Thl-Th2 polarity in kidney ischemia-reperfusion injury", J Immunol., (20120000), vol. 189, no. 5, pages 2584 - 96 | - BALTHASAR SSAMULIN JAHLGREN HBERGELIN NLUNDQVIST MTOESCU ECEGGO MCTOMQUIST K., "Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells", Biochem J., (20060000), vol. 398, no. 3, pages 547 - 56 | - BRINKMANN V., "FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system", Br J Pharmacol, (20090000), vol. 158, no. 5, doi:10.1111/j.1476-5381.2009.00451.x, pages 1173 - 82, XP055298006 DOI: http://dx.doi.org/10.1111/j.1476-5381.2009.00451.x | - BRINKMANN V., "Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology", Pharmacol Ther, (20070000), vol. 115, no. 1, doi:10.1016/j.pharmthera.2007.04.006, pages 84 - 105, XP022134156 DOI: http://dx.doi.org/10.1016/j.pharmthera.2007.04.006 | - BRADL MHOHLFELD R., "Molecular pathogenesis of neuroinflammation", J Neurol Neurosurg Psychiatry, (20030000), vol. 74, no. 10, pages 1364 - 70 | - CASAMENTI FPROSPERI CSCALI CGIOVANNELLI LPEPEU G., "Morphological, biochemical and behavioural changes induced by neurotoxic and inflammatory insults to the nucleus basalis.", Int J Dev Neurosci, (19980000), vol. 16, pages 7 - 8 | - CENCETTI FBERNACCHIONI CNINCHERI PDONATI CBRUNI P., "Transforming growth factor-betal induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis", Mol Biol Cell, (20100000), vol. 21, no. 6, pages 1111 - 24 | - CHEN LYWOSZCZEK GNAGINENI SLOGUN CSHELHAMER JH, "Cytosolic phospholipase A2alpha activation induced by SIP is mediated by the S1P3 receptor in lung epithelial cells", Am J Physiol Lung Cell Mol Physiol., (20080000), vol. 295, no. 2, pages L326 - 35 | - CHUN JGOETZL EJHLA TIGARASHI YLYNCH KRMOOLENAAR W., "International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature", Pharmacol Rev, (20020000), vol. 54, doi:10.1124/pr.54.2.265, pages 265 - 269, XP002260722 DOI: http://dx.doi.org/10.1124/pr.54.2.265 | - DAVIES LFASSBENDER KWALTER S, "Sphingolipids in neuroinflammation", Handb Exp Pharmacol, (20130000), no. 216, pages 421 - 30 | - ENNACEUR ADELACOUR J, "A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data", Behav Brain Res, (19880000), vol. 31, no. 1, doi:10.1016/0166-4328(88)90157-X, pages 47 - 59, XP024531498 DOI: http://dx.doi.org/10.1016/0166-4328(88)90157-X | - FORREST MSUN SYHAJDU RBERGSTROM JCARD DDOHERTY GHALE JKEOHANE CMEYERS CMILLIGAN J, "Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes", J Pharmacol Exp Ther, (20040000), vol. 309, no. 2, doi:10.1124/jpet.103.062828, pages 758 - 68, XP055325255 DOI: http://dx.doi.org/10.1124/jpet.103.062828 | - FISCHER IALLIOD CMARTINIER NNEWCOMBE JBRANA CPOULY S, "Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions", PLoS One, (20110000), vol. 6, no. 8, page e23905 | - FOSTER CAHOWARD LMSCHWEITZER APERSOHN EHIESTAND PCBALATONI BREUSCHEL RBEERLI CSCHWARTZ MBILLICH A, "Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis", J Pharmacol Exp Ther, (20070000), vol. 323, no. 2, pages 469 - 75 | - GUDE DRALVAREZ SEPAUGH SWMITRA PYU JGRIFFITHS RBARBOUR SEMILSTIEN SSPIEGEL S., "Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a ''come-and-get-me'' signal", FASEB J., (20080000), vol. 22, no. 8, pages 2629 - 38 | - HARRIS GLCREASON MBBRULTE GBHERR DR, "In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody", PLoS One., (20120000), vol. 7, no. 4, doi:10.1371/journal.pone.0035129, page e35129, XP055029982 DOI: http://dx.doi.org/10.1371/journal.pone.0035129 | - ISHII IFRIEDMAN BYE XKAWAMURA SMCGIFFERT CCONTOS JJKINGSBURY MAZHANG GBROWN JHCHUN J., "Selective Loss of Sphingosine 1-Phosphate Signaling with No Obvious Phenotypic Abnormality in Mice Lacking Its G Protein coupled Receptor, LPB3/EDG-3", J Biol Chem., (20010000), vol. 276, no. 36, pages 33697 - 704 | - ISHII IFUKUSHIMA NYE XCHUN J., "Lysophospholipid Receptors: Signaling and Biology", Annu Rev Biochem, (20040000), vol. 73, doi:10.1146/annurev.biochem.73.011303.073731, pages 321 - 54, XP008043417 DOI: http://dx.doi.org/10.1146/annurev.biochem.73.011303.073731 | - KANNO TNISHIZAKI T, "Endogenous sphingosine 1-phosphate regulates spontaneous glutamate release from mossy fiber terminals via S1P(3) receptors", Life Sci, (20110000), vol. 89, no. 3-4, pages 137 - 40 | - KEUL PLUCKE SVON WNUCK LIPINSKI KBODE CGRALER MHEUSCH GLEVKAU B, "Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis", Circ Res, (20110000), vol. 108, no. 3, pages 314 - 23 | - KIM ESKIM JSKIM SGHWANG SLEE CHMOON A, "Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-Gaq coupling", J Cell Sci, (20110000), vol. 124, pages 2220 - 30 | - KONO MMI YLIU YSASAKI TALLENDE MLWU YPYAMASHITA TPROIA RL, "The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis", J Biol Chem., (20040000), vol. 279, no. 28, pages 29367 - 73 | - KONO YNISHIUMA TNISHIMURA YKOTANI YOKADA TNAKAMURA SYOKOYAMA M, "Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-betal", Am J Respir Cell Mol Biol, (20070000), vol. 37, no. 4, pages 395 - 404 | - LAI WQMELENDEZ AJLEUNG BP, "Role of sphingosine kinase and sphingosine-1-phosphate in inflammatory arthritis", World J Biol Chem., (20100000), vol. 1, no. 11, pages 321 - 326 | - LI CJIANG XYANG LLIU XYUE SLI L., "Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis induced liver fibrosis", Am J Pathol, (20090000), vol. 175, no. 4, pages 1464 - 72 | - LILIOM KGUAN ZTSENG JLDESIDERIO DMTIGYI GWATSKY MA, "Growth factor-like phospholipids generated after corneal injury", Am J Physiol, (19980000), vol. 274, pages C1065 - C1074 | - MACEYKA MHARIKUMAR KBMILSTIEN SSPIEGEL S, "Sphingosine-1-phosphate signaling and its role in disease", Trends Cell Biol, (20120000), vol. 22, no. l, doi:10.1016/j.tcb.2011.09.003, pages 50 - 60, XP028122823 DOI: http://dx.doi.org/10.1016/j.tcb.2011.09.003 | - MARAGAKIS NJROTHSTEIN JD, "Mechanisms of Disease: astrocytes in neurodegenerative disease", Nat Clin Pract Neurol, (20060000), vol. 2, no. 12, pages 679 - 89 | - MARSOLAIS DROSEN H, "Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules", Nat Rev Drug Discov, (20090000), vol. 8, no. 4, doi:10.1038/NRD2356, pages 297 - 307, XP002617578 DOI: http://dx.doi.org/10.1038/NRD2356 | - MEANS KLBROWN JH, Cardiov Res Sphingosine-1-phosphate receptor signalling in the heart, (20090000), vol. 82, pages 193 - 200 | - MEHTA DKONSTANTOULAKI MAHMMED GUMALIK AB, "Sphingosine 1-phosphate-induced mobilization of intracellular Ca2+ mediates Rac activation and adherents junction assembly in endothelial cells", J Biol Chem., (20050000), vol. 280, pages 17320 - 17328 | - MERAZ-RIOS MATORAL-RIOS DFRANCO-BOCANEGRA DVILLEDA-HERNANDEZ JCAMPOS-PENA V., "Inflammatory process in Alzheimer's Disease", Front Integr Neurosci, (20130000), vol. 7, no. 59, pages 1 - 15 | - METTU PDENG PMISRA UGAWDI GEPSTEIN DRAO P, "Role of lysophopholipid growth factors in the modulation of aqueous humor outflow facility", Invest. Ophthalmol. Vis. Sci., (20040000), vol. 45, pages 2263 - 2271 | - MURAKAMI ATAKASUGI HOHNUMA SKOIDE YSAKURAI ATAKEDA SHASEGAWA TSASAMORI JKONNO THAYASHI K, "Sphingosine 1-phosphate (SIP) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist", Mol Pharmacol., (20100000), vol. 77, no. 4, doi:10.1124/mol.109.061481, pages 704 - 13, XP055437457 DOI: http://dx.doi.org/10.1124/mol.109.061481 | - NIESSEN FSCHAFFHER FFURLAN-FREGUIA CPAWLINSKI RBHATTACHARJEE GCHUN JDERIAN CKANDRADE-GORDON PROSEN HRUF W, "Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation", Nature, (20080000), vol. 452, no. 7187, pages 654 - 8 | - PAXINOS, G.WATSON, C.PENNISI, M.TOPPLE, A., "Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight", J. Neurosci. Methods, (19850000), vol. 13, doi:10.1016/0165-0270(85)90026-3, pages 139 - 143, XP025435979 DOI: http://dx.doi.org/10.1016/0165-0270(85)90026-3 | - PYNE SPYNE JN, "Sphingosine 1-phosphate signalling in mammalian cells", BiochemJ, (20000000), vol. 349, doi:10.1042/0264-6021:3490385, pages 385 - 402, XP000939036 DOI: http://dx.doi.org/10.1042/0264-6021:3490385 | - ROSEN HGONZALEZ-CABRERA PJSANNA MGBROWN S, "Sphingosine 1-phosphate receptor signaling", Annu Rev Biochem, (20090000), vol. 78, doi:10.1146/annurev.biochem.78.072407.103733, pages 743 - 68, XP055004703 DOI: http://dx.doi.org/10.1146/annurev.biochem.78.072407.103733 | - ROUACH NPEBAY AMEME WCORDIER JEZAN PETIENNE EGIAUME CTENCE M, "SIP inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK", Eur J Neurosci, (20060000), vol. 23, no. 6, pages 1453 - 1464 | - SCALI CGIOVANNINI MGPROSPERI CBARTOLINI LPEPEU G, "Tacrine administration enhances extracellular acetylcholine in vivo and restores the cognitive impairment in aged rats", Pharmacol Res, (19970000), vol. 36, pages 463 - 469 | - SANNA MGLIAO JJO EALFONSO CAHN MYPETERSON MSWEBB BLEFEBVRE SCHUN JGRAYN, "Sphingosine 1-Phosphate (SIP) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate", J Biol Chem., (20040000), vol. 279, no. 14, doi:10.1074/jbc.m311743200, pages 13839 - 48, XP002689287 DOI: http://dx.doi.org/10.1074/jbc.m311743200 | - SHEA BSTAGER AM, Open Rheumat J., (20120000), vol. 6, pages 123 - 129 | - SINGLETON PADUDEK SMMA SFGARCIA JG, "Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family", J Biol Chem., (20060000), vol. 281, no. 45, pages 34381 - 93 | - SPIEGEL SMILSTIEN S, "Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways", Biochem Soc Trans, (20030000), vol. 31, pages 1216 - 9 | - STAMER WDREAD ATSUMIDA GMETHIER CR, "Sphingosine-1-phosphate effects on the inner wall of Schlemm's canal and outflow facility in perfused human eyes", Exp Eye Res, (20090000), vol. 89, no. 6, doi:10.1016/j.exer.2009.08.008, pages 980 - 8, XP026747521 DOI: http://dx.doi.org/10.1016/j.exer.2009.08.008 | - SUN XSHIKATA YWANG LOHMORI KWATANABE NWADA JSHIKATA KBIRUKOV KG, "Enhanced interaction between ", Microvasc Res, (20090000), vol. 77, doi:10.1016/j.mvr.2008.12.004, pages 304 - 313, XP026038710 DOI: http://dx.doi.org/10.1016/j.mvr.2008.12.004 | - TAKASUGI NSASAKI TSUZUKI KOSAWA SISSHIKI HHORI YSHIMADA NHIGO TYOKOSHIMA SFUKUYAMA T, "BACE1 activity is modulated by cell-associated sphingosine-1-phosphate", J Neurosci, (20110000), vol. 31, no. 18, pages 6850 - 7 | - TAKUWA NOHKURA STAKASHIMA SOHTANI KOKAMOTO YTANAKA THIRANO KUSUI SWANG FDU W, "SIP3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species", Cardiovasc Res, (20100000), vol. 85, no. 3, pages 484 - 93 | - TANIGUCHI MKITATANI KKONDO THASHIMOTO-NISHIMURA MASANO SHAYASHI AMITSUTAKE SIGARASHI YUMEHARA HTAKEYA H, "Regulation of autophagy and its associated cell death by ''sphingolipid rheostat'': reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway", J Biol Chem., (20120000), vol. 287, no. 47, pages 39898 - 910 | - TRIFILIEFF AFOZARD JR, "Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor", J Pharmacol Exp Ther, (20120000), vol. 342, no. 2, pages 399 - 406 | - UHLIG SYANG Y, "Sphingolipids in Disease. Handbook of Experimental Pharmacology", Sphingolipids in Acute Lung Injury, (20130000), vol. 216, pages 227 - 246 | - WELCH SPSIM-SELLEY LJSELLEY DE, "Sphingosine-1-phosphate receptors as emerging targets for treatment of pain", Biochem Pharmacol, (20120000), vol. 84, no. 12, doi:10.1016/j.bcp.2012.08.010, pages 1551 - 62, XP055363244 DOI: http://dx.doi.org/10.1016/j.bcp.2012.08.010 | - WU YPMIZUGISHI KBEKTAS MSANDHOFF RPROIA RL, "Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease", Hum Mol Genet, (20080000), vol. 17, no. 15, pages 2257 - 64 | - YAMASHITA HKITAYAMA JSHIDA DYAMAGUCHI HMORI KOSADA MAOKI SYATOMI YTAKUWA YNAGAWA H, "Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation", J Surg Res, (20060000), vol. 130, no. 1, doi:10.1016/j.jss.2005.08.004, pages 80 - 7, XP024952494 DOI: http://dx.doi.org/10.1016/j.jss.2005.08.004 | - YIN ZFAN LWEI LGAO HZHANG RTAO LCAO FWANG H, "FTY720 protects cardiac microvessels of diabetes: a critical role of S1P1/3 in diabetic heart disease", PLoS One., (20120000), vol. 7, no. 8, page e42900 | - YOUNG NVAN BROCKLYN JR, "Roles of Sphingosine-1-Phosphate (SIP) Receptors in Malignant behavior of Glioma Cells. Differential Effects of S1P2 on Cell Migration and Invasiveness", Exp Cell Res., (20070000), vol. 313, no. 8, doi:10.1016/j.yexcr.2007.02.009, pages 1615 - 1627, XP022030164 DOI: http://dx.doi.org/10.1016/j.yexcr.2007.02.009 | - ZHANG YHFEHRENBACHER JCVASKO MRNICOLL GD, "Sphingosine-1-Phosphate Via Activation of a G-Protein-Coupled Receptor(s) Enhances the Excitability of Rat Sensory Neurons", J Neurophysiol, (20060000), vol. 96, doi:10.1152/jn.00120.2006, pages 1042 - 1052, XP002488948 DOI: http://dx.doi.org/10.1152/jn.00120.2006 | - LILIOM KGUAN ZTSENG JLDESIDERIO DMTIGYI GWATSKY MA, "Growth factor-like phospholipids generated after corneal injury", Am J Physiol., (19980000), vol. 274, pages C1065 - C1074 | - CASAMENTI FPROSPERI CSCALI CGIOVANNELLI LPEPEU G., "Morphological, biochemical and behavioural changes induced by neurotoxic and inflammatory insults to the nucleus basalis.", Int J Dev Neurosci., (19980000), vol. 16, pages 7 - 8 |